<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药时代 | wechat-feeds</title><link>http://MzI5NzY0NDQyNQ.favicon.privacyhide.com/favicon.ico</link><description>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康和希望！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 30 May 2021 17:46:01 +0800</pubDate><image><url>http://MzI5NzY0NDQyNQ.favicon.privacyhide.com/favicon.ico</url><title>药时代 | wechat-feeds</title><link>http://MzI5NzY0NDQyNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>First-in-Class！与药时代大咖共进午餐，您准备好了吗？</title><link>https://mp.weixin.qq.com/s/DCyJinAZc5Zh1exUed4q4w</link><description></description><content:encoded><![CDATA[First-in-Class！与药时代大咖共进午餐，您准备好了吗？]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>率先突围，百时美施贵宝S1PR调节剂ozanimod获批治疗溃疡性结肠炎</title><link>https://mp.weixin.qq.com/s/eUXD80hJMZ4GgD2VDlCIXw</link><description></description><content:encoded><![CDATA[率先突围，百时美施贵宝S1PR调节剂ozanimod获批治疗溃疡性结肠炎]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>Viruses：新基因测定法助力新冠药物大洗牌</title><link>https://mp.weixin.qq.com/s/5UB_Crpv6r7GJruQ5hACUg</link><description></description><content:encoded><![CDATA[Viruses：新基因测定法助力新冠药物大洗牌]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>老药新用：FDA受理乌地那非新适应症上市申请，已授予优先审评</title><link>https://mp.weixin.qq.com/s/RKBSCDB1bO1uyGsSc7dGgg</link><description></description><content:encoded><![CDATA[老药新用：FDA受理乌地那非新适应症上市申请，已授予优先审评]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>【Nature cancer】非小细胞肺癌中EGFR抑制剂耐药的最新进展</title><link>https://mp.weixin.qq.com/s/ekvvJjaAUC3vX4eksNaTBw</link><description></description><content:encoded><![CDATA[【Nature cancer】非小细胞肺癌中EGFR抑制剂耐药的最新进展]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>抗体类药物研发生产现状分析</title><link>https://mp.weixin.qq.com/s/psXJcQmVkDuMuUEPz4g2Gw</link><description></description><content:encoded><![CDATA[抗体类药物研发生产现状分析]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>重磅！国研自强！国产CAR-T疗法达100%缓解！长期有效！《Blood》最新研究</title><link>https://mp.weixin.qq.com/s/8t9zBxk1FRLe2ObTVsWP_Q</link><description></description><content:encoded><![CDATA[重磅！国研自强！国产CAR-T疗法达100%缓解！长期有效！《Blood》最新研究]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>常喝牛奶，容易胖但胆固醇更低？</title><link>https://mp.weixin.qq.com/s/NTK1DkOdcrWtvbVNZAjvyw</link><description></description><content:encoded><![CDATA[常喝牛奶，容易胖但胆固醇更低？]]></content:encoded><pubDate>Sun, 30 May 2021 17:00:30 +0800</pubDate></item><item><title>​众望所归！FDA加速批准安进AMG 510上市｜首款针对KRAS G12C 突变的靶向药物</title><link>https://mp.weixin.qq.com/s/QrOCBuWRGXa3CWsiiqvrZA</link><description></description><content:encoded><![CDATA[​众望所归！FDA加速批准安进AMG 510上市｜首款针对KRAS G12C 突变的靶向药物]]></content:encoded><pubDate>Sat, 29 May 2021 17:09:52 +0800</pubDate></item><item><title>重磅消息扎堆！再鼎医药瑞派替尼商业上市、人福药业1类新药获批、阿斯利康与绿叶又一交易达成、基石药业泰吉华商业化上市。。。</title><link>https://mp.weixin.qq.com/s/mEnIJPIJ_xpwLq54oxJDsQ</link><description></description><content:encoded><![CDATA[重磅消息扎堆！再鼎医药瑞派替尼商业上市、人福药业1类新药获批、阿斯利康与绿叶又一交易达成、基石药业泰吉华商业化上市。。。]]></content:encoded><pubDate>Sat, 29 May 2021 17:09:52 +0800</pubDate></item><item><title>一致性评价Top10品种分析：过评339个，齐鲁一骑红尘，石药、科伦紧跟</title><link>https://mp.weixin.qq.com/s/lrSCOgadb5XfB4lHgMfa7w</link><description></description><content:encoded><![CDATA[一致性评价Top10品种分析：过评339个，齐鲁一骑红尘，石药、科伦紧跟]]></content:encoded><pubDate>Sat, 29 May 2021 17:09:52 +0800</pubDate></item><item><title>高端访谈|荣昌生物房健民：创新药需优化创新环境，提升风险承受力及科研转化率！</title><link>https://mp.weixin.qq.com/s/P444O13ccP174CLjLOGCFA</link><description></description><content:encoded><![CDATA[高端访谈|荣昌生物房健民：创新药需优化创新环境，提升风险承受力及科研转化率！]]></content:encoded><pubDate>Sat, 29 May 2021 17:09:52 +0800</pubDate></item><item><title>安进新一代拟钙剂依特卡肽即将国内获批上市，疗效不输西那卡塞</title><link>https://mp.weixin.qq.com/s/7z5Yc_nW1bhr2g15Yv7LBA</link><description></description><content:encoded><![CDATA[安进新一代拟钙剂依特卡肽即将国内获批上市，疗效不输西那卡塞]]></content:encoded><pubDate>Sat, 29 May 2021 17:09:52 +0800</pubDate></item><item><title>填补空白：中国首个PI3Kδ抑制剂上市在即！来自璎黎药业</title><link>https://mp.weixin.qq.com/s/cesreGZJkxT0hV1vqW0oPQ</link><description></description><content:encoded><![CDATA[填补空白：中国首个PI3Kδ抑制剂上市在即！来自璎黎药业]]></content:encoded><pubDate>Sat, 29 May 2021 17:09:52 +0800</pubDate></item><item><title>科普｜Cell Reports Medicine：肥胖会使脂肪组织发生这些变化</title><link>https://mp.weixin.qq.com/s/nE-fcWFJmiC6gYfpJ2kUhg</link><description></description><content:encoded><![CDATA[科普｜Cell Reports Medicine：肥胖会使脂肪组织发生这些变化]]></content:encoded><pubDate>Sat, 29 May 2021 17:09:52 +0800</pubDate></item><item><title>中国好BD｜绿叶制药</title><link>https://mp.weixin.qq.com/s/ztUTU6ekum6hHdwuAEHwfg</link><description></description><content:encoded><![CDATA[中国好BD｜绿叶制药]]></content:encoded><pubDate>Fri, 28 May 2021 16:58:01 +0800</pubDate></item><item><title>五年生存率高达31.9%，帕博利珠单抗让晚期肺癌治愈成为可能</title><link>https://mp.weixin.qq.com/s/ufJhWI6f7YQWRAe2bFsLlQ</link><description></description><content:encoded><![CDATA[五年生存率高达31.9%，帕博利珠单抗让晚期肺癌治愈成为可能]]></content:encoded><pubDate>Fri, 28 May 2021 16:58:01 +0800</pubDate></item><item><title>NASH update (May 24th): FGF19 Aldafermin Ph2b ALPINE2/3 data</title><link>https://mp.weixin.qq.com/s/uwN4pMHtVIeLKSl3aQFuBA</link><description></description><content:encoded><![CDATA[NASH update (May 24th): FGF19 Aldafermin Ph2b ALPINE2/3 data]]></content:encoded><pubDate>Fri, 28 May 2021 16:58:01 +0800</pubDate></item><item><title>最新！基药扩容，新增270个品种？哪些品种将优先入围集采？</title><link>https://mp.weixin.qq.com/s/idrlQYeAQfTR7vbeMyWhoA</link><description></description><content:encoded><![CDATA[最新！基药扩容，新增270个品种？哪些品种将优先入围集采？]]></content:encoded><pubDate>Fri, 28 May 2021 16:58:01 +0800</pubDate></item><item><title>风风雨雨二十年，激酶抑制剂的未来在何方？</title><link>https://mp.weixin.qq.com/s/Rs87BRRHN0k-XjH86aTHJw</link><description></description><content:encoded><![CDATA[风风雨雨二十年，激酶抑制剂的未来在何方？]]></content:encoded><pubDate>Fri, 28 May 2021 16:58:01 +0800</pubDate></item></channel></rss>